The Lundbeck Foundation Research Center MIND, Department of Medical Biochemistry, Aarhus University, Denmark.
Cell Metab. 2010 Sep 8;12(3):213-23. doi: 10.1016/j.cmet.2010.08.006.
Recent genome-wide association studies (GWAS) have revealed strong association of hypercholesterolemia and myocardial infarction with SNPs on human chromosome 1p13.3. This locus covers three genes: SORT1, CELSR2, and PSRC1. We demonstrate that sortilin, encoded by SORT1, is an intracellular sorting receptor for apolipoprotein (apo) B100. It interacts with apoB100 in the Golgi and facilitates the formation and hepatic export of apoB100-containing lipoproteins, thereby regulating plasma low-density lipoprotein (LDL) cholesterol. Absence of sortilin in gene-targeted mice reduces secretion of lipoproteins from the liver and ameliorates hypercholesterolemia and atherosclerotic lesion formation in LDL receptor-deficient animals. In contrast, sortilin overexpression stimulates hepatic release of lipoproteins and increases plasma LDL levels. Our data have uncovered a regulatory pathway in hepatic lipoprotein export and suggest a molecular explanation for the cardiovascular risk being associated with 1p13.3.
最近的全基因组关联研究(GWAS)表明,胆固醇过高和心肌梗死与人类 1p13.3 染色体上的 SNP 有很强的关联。这个基因座包含三个基因:SORT1、CELSR2 和 PSRC1。我们证明,SORT1 编码的 sortilin 是载脂蛋白(apo)B100 的细胞内分拣受体。它在高尔基体中与 apoB100 相互作用,并促进 apoB100 含有脂蛋白的形成和肝脏输出,从而调节血浆低密度脂蛋白(LDL)胆固醇。基因靶向小鼠中 sortilin 的缺失减少了肝脏脂蛋白的分泌,并改善了 LDL 受体缺陷动物的高胆固醇血症和动脉粥样硬化病变形成。相比之下,sortilin 的过表达刺激了肝脏释放脂蛋白并增加了血浆 LDL 水平。我们的数据揭示了肝脏脂蛋白输出的调节途径,并为与 1p13.3 相关的心血管风险提供了分子解释。